PACB vs VREX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

PACB

38.9
AI Score
VS
VREX Wins

VREX

43.3
AI Score

Investment Advisor Scores

PACB

39score
Recommendation
SELL

VREX

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PACB VREX Winner
Revenue 76.19M 636.10M VREX
Net Income -53.02M 9.90M VREX
Gross Margin 33.4% 34.4% VREX
Net Margin -69.6% 1.6% VREX
Operating Income -52.97M 52.60M VREX
ROE 159.6% 2.0% PACB
ROA -7.1% 0.9% VREX
Total Assets 751.85M 1.10B VREX
Cash 61.00M 99.20M VREX
Current Ratio 4.92 3.38 PACB
Free Cash Flow -84.87M -22.50M VREX

Relative Price Performance (Last 90 Days)

PACB 1M: +17.1% · 3M: -3.7% VREX 1M: +0.1% · 3M: +67.4%

Current Technical Phase

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $1.30

VREX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (28.2% over 20 days), RSI 86

RSI (14): 85.9 · Price: $18.46

Fundamentals Snapshot

Metric PACB VREX
Market Cap
Forward P/E -3.2 17.3
Trailing P/E 34.8
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin -1.1% 0.1%
EPS -0.41 0.53
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, VREX is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.